Home > Insider Trading > Filing (0001144204-11-038974)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1095858	Ivax Diagnostics Inc	IVD	Pharmaceutical Preparations (2834)	113500746

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1500199	Kishore Dudani	Transasia House 8 Chandivali Studio Road Mumbai IN 400072		Yes	No	Yes	No
1500200	Gmbh Mannheim Diagnostics Erba	Mallaustr 69-73 Mannheim 2M 68219		Yes	No	Yes	No
1500201	Ltd. Bio-Medicals Transasia	Transasia House 8 Chandivali Studio Road Mumbai IN 400072		No	No	Yes	No
1500202	H. Suresh Vazirani	Transasia House 8 Chandivali Studio Road Mumbai IN 400072	Executive Chairman Of Board	Yes	Yes	Yes	No
1500277	S.r.o. Lachema Erba	Karasek 1D Brno 2N 62133		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	Acquisiton	2011-07-01	20,000,000	$0.75	40,026,313	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.01 Par Value	Common Stock Warrants (right to buy)	Acquisiton	2011-07-01	20,000,000	$0.00	20,000,000	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000,000	2011-07-01	2016-07-01	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	8,400	Indirect	By subsidiary

Footnotes

On July 1, 2011, the issuer sold and issued to ERBA Diagnostics Mannheim GmbH ("ERBA"), in a privately negotiated transaction pursuant to a stock purchase agreement, an aggregate of 20,000,000 shares of the issuer's common stock at a purchase price of $0.75 per share and warrants to purchase an additional 20,000,000 shares of the issuer's common stock.
These shares were acquired under a stock purchase agreement pursuant to which (a) 6,666,667 shares were issued and delivered to ERBA upon ERBA's payment to the issuer of $5,000,000.25, (b) 6,666,667 shares will be issued and delivered to ERBA upon ERBA's payment to the issuer of $5,000,000.25 by no later than January 1, 2012 and (c) 6,666,666 shares will be issued and delivered to ERBA upon ERBA's payment to the issuer of $4,999,999.50 by no later than July 1, 2012.
These shares are held directly by ERBA and indirectly by Transasia Bio-medicals Ltd., its corporate parent, and Suresh H. Vazirani, its controlling shareholder.
These shares are held by Erba Lachema s.r.o., a direct wholly-owned subsidiary of ERBA.
These warrants are held directly by ERBA and indirectly by Transasia Bio-medicals Ltd., its corporate parent, and Suresh H. Vazirani, its controlling shareholder.
All of the reporting persons may be deemed to have beneficial ownership with respect to these securities, however, each reporting person disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein.